Enews from the Alzheimer's Association

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.
March 17, 2021
 
24/7 Helpline: 800.272.3900
Experimental Alzheimer's drug may slow cognitive decline
The experimental intravenous drug donanemab may slow cognitive decline in people living with Alzheimer's, according to a Phase 2 clinical trial. Researchers found that the drug slowed the decline of cognition and daily function in participants by 32 percent after 76 weeks compared to those who received a placebo. The research is early, but Maria Carrillo, Alzheimer’s Association chief science officer, says the drug “could be a first step toward slowing more significantly, or stopping, cognitive decline in these earlier stages."

Click here to read more
Grab your bike and ride with us this spring
Whether you’re experienced or just starting out, the Alzheimer’s Association has a number of different cycling events designed for riders of all skill levels to join the cause. Find an in-person or virtual event, and ride to raise funds to help end Alzheimer’s.
Click here to read more
Help fight Alzheimer's
Your Local Community
 
Marshalls accelerates the fight to end Alzheimer’s
Through March 27, Marshalls customers nationwide will have the opportunity to donate at checkout to benefit Alzheimer’s Association care, support and research efforts. Since 2013, Marshalls has raised over $10 million to support the Association’s vision of a world without Alzheimer’s and all other dementia.
Click here to read more
Create a free, customized action plan with Alzheimer's Navigator.
 
More Resources: 
Behaviors  | 
My Preferences:
Unsubscribe
To stop receiving our weekly e-newsletter, simply unsubscribe.
 
Subscribe
Was this e-newsletter forwarded to you? Subscribe to get it weekly.
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.

Alzheimer's Association Home Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2021 Alzheimer's Association. All rights reserved. www.alz.org | 800.272.3900.